SCHEMBL4220566

SCHEMBL4220566

CN(C(=O)CNC(c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.48
PPIB P23284 1/20 0.47
KMT2A Q03164 5/20 0.45
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 4/20 0.44
LMNA P02545 1/20 0.44
MTOR P42345 1/20 0.44
RAB9A P51151 1/20 0.44
GRM7 Q14831 1/20 0.44
CYP3A4 P08684 2/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
TACR1 P25103 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
POLQ O75417 1/20 0.42
KDM4E B2RXH2 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4232629 0.83 KMT2A (0.50) TDP1KMT2AALDH1A1MEN1LMNA
SCHEMBL10702563 0.83 PPIB (0.49) PPIBKMT2AALDH1A1MEN1LMNA
Hydrochloric Acid SCHEMBL4227039 0.80 ALDH1A1 (0.56) TDP1KMT2AALDH1A1MEN1LMNA
Hydrochloric Acid SCHEMBL4228085 0.78 PPIB (0.45) PPIBKMT2AALDH1A1MEN1CYP3A4
SCHEMBL1818383 0.78 PPIB (0.52) PPIBKMT2AALDH1A1MEN1LMNA
SCHEMBL1821412 0.78 PPIB (0.52) PPIBKMT2AALDH1A1MEN1LMNA
SCHEMBL1760632 0.77 KMT2A (0.58) PPIBKMT2AALDH1A1MEN1LMNA
SCHEMBL14667454 0.76 PPIB (0.55) PPIBKMT2AALDH1A1MEN1CYP3A4
SCHEMBL1821351 0.76 PPIB (0.51) PPIBKMT2AALDH1A1MEN1CYP3A4
Hydrochloric Acid SCHEMBL4236104 0.76 NPC1 (0.55) TDP1KMT2AALDH1A1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096104-A1 Organic diamines as mGluR7 modulators Novartis AG (CH) 2009-09-02 EP disclosed
US-20080242698-A1 Organic Compounds NOVARTIS AG (CH) 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242698-A1 Organic Compounds AOC1, OTC, ODC1 TDP1 1575/4885PPIB 1105/4885KMT2A 1438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.